Effects of human milk fortification on morbidity factors in very low birth weight infants.

Effects of human milk fortification on morbidity factors in very low birth weight infants. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Effects of human milk fortification on morbidity factors in very low birth weight infants. Abstract Text:

Bashir Ahmad Bhat,Bhaskar Gupta,

Background: The use of human milk as a sole source of nutrients for preterm infants has been the subject of debate in recent years. We studied the morbidity factors associated with hospitalization of very low birth weight (VLBW) infants fed human milk with and without fortification. Patients and Methods: One hundred VLBW infants were randomly assigned to two groups with stratification for gestation and weight. The control group (n-50; mean birth weight 1239+/-186 g and mean gestation 29.3+/-2.1 wks) was fed human milk only, and in the fortifier group (n=50; mean birth weight 1245+/-191 g and mean gestation 29.5+/-2.1 wks), human milk was enriched with a fortifier after the babies reached a volume of 140 mL/kg/day by the enteral route. Weight was measured twice weekly, biochemical indices of nutritional and bone status and serum electrolytes were obtained weekly, and clinical evidence for sepsis, necrotizing enterocolitis and feeding intolerance was assessed regularly until infants were discharged. Results: Hospital stay was less than 45 days in the majority (94%) of the babies in the fortifier group, whereas the majority (66%) of the babies in the control group stayed for more than 45 days (P<0.01). Low serum phosphorus and raised alkaline phosphate levels were seen more frequently in the control group without fortification (p<0.01), as weel as hyponatremia (P<0.01), late metabolic acidosis of prematurity (P<0.01) and culture-proven sepsis (p<0.05). There was no significant difference in the occurrence of necrotizing enterocolitis between the two groups (P>0.05). Conclusion: Human milk fortification has beneficial effects on the growth of VLBW infants and decreases hospital stay and morbidity associated with prematurity and very low birth weight, with economic and psychological benefits for the parents.

Effects of human milk fortification on morbidity factors in very low birth weight infants. Publishing Authors By Initials

BA Bhat,B Gupta,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Effects of human milk fortification on morbidity factors in very low birth weight infants. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Annals of Saudi medicine

VOLUME: 23

Page Numbers: 28-31

Journal Abbreviation:

ISSN: 0256-4947

DAY: 5

MONTH: 12

YEAR: 2006

Effects of human milk fortification on morbidity factors in very low birth weight infants. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8507355

Effects of human milk fortification on morbidity factors in very low birth weight infants. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Effects of human milk fortification on morbidity factors in very low birth weight infants. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Effects of human milk fortification on morbidity factors in very low birth weight infants.

AFFILIATION: Department of Pediatrics, Special Care Baby Unit, Khoula Hospital, Muscat, Oman.

Country: Saudi Arabia

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Ann Saudi Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Effects of human milk fortification on morbidity factors in very low birth weight infants Related Publications

• Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection.
• Ano-perianal tuberculosis - solving a clinical dilemma.
• Apigenin and cancer chemoprevention: progress, potential and promise (review).
• Aripiprazole worsens psychosis: a case report.
• Association of leupaxin with Src in osteoclasts.
• Brief treatment guide for onychomycosis.
• Chemical Components of Cuphea Species. Carthagenol: A New Triterpene from C. carthagenensis.
• Demyelination secondary to chronic nerve compression injury alters Schmidt-Lanterman incisures.
• Directive and nondirective spousal support: differential effects?
• Effect of processing variables on texture development in a mica-based glass-ceramic.
• Effects of human milk fortification on morbidity factors in very low birth weight infants.
• Feasibility of day care surgery in proctology.
• Hepatocellular carcinoma metastasis to maxillary antrum.
• Median cleft face syndrome.
• Modulation of novel DNA adducts during human uterine cervix cancer progression.
• Monocrotaline promotes transplanted cell engraftment and advances liver repopulation in rats via liver conditioning.
• Multitherapy approach to onychomycosis therapy.
• Net gain: a new method for preventing malaria deaths.
• Photochemistry of Desonide, a Non-fluorinated Steroidal Anti-inflammatory Drug.
• Predictors of screening for breast and colorectal cancer among middle-aged women.
• Rapid diagnosis of community-acquired pneumonia using the Bac T/ alert 3D system.
• Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns.
• Serendipitous detection of testicular seminoma on F-18 FDG positron tomography.
• Seroprevalence and correlates of herpes simplex virus type-2 infection in a general gynecology clinic.
• Structural and functional diversities in lepidopteran serine proteases.
• The peptidoglycan recognition proteins (PGRPs).
• Transplantation of preconditioned schwann cells in peripheral nerve grafts after contusion in the adult spinal cord. Improvement of recovery in a rat model.
• Treatment of fissure in ano- revisited.
• Up-regulation of m-opioid receptors in the spinal cord of morphine-tolerant rats.
• Zero-crossing iso-surfaces in volume datasets.